Back to search

Short- and Long-Term Risk Stratification in Acute Coronary Syndromes

Data up to Jan 2025

Published2006
Citations80
References35

Total Citations Per Year

Abstract

References (35)

Prediction of Creatinine Clearance from Serum Creatinine

1976 • 15,066 citations

ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

2000 • 4,662 citations

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

2000 • 3,097 citations

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

2001 • 2,126 citations

A Validated Prediction Model for All Forms of Acute Coronary Syndrome

2004 • 1,536 citations

The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes

2001 • 1,306 citations

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

2000 • 1,220 citations

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article

2002 • 1,109 citations

Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation

2000 • 942 citations

ACC/AHA guideline for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction

2002 • 868 citations

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article

2002 • 835 citations

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

2000 • 754 citations

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

2001 • 704 citations

N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease

2003 • 597 citations

N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes

2002 • 569 citations

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

2005 • 543 citations

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis

2000 • 414 citations

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

2003 • 366 citations

The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.

1997 • 357 citations

Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction

2002 • 345 citations

Acute Coronary Syndromes in the GUSTO-IIb Trial

1998 • 259 citations

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men?

2001 • 256 citations

Renal function: the Cinderella of cardiovascular risk profile

2001 • 203 citations

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes

2002 • 158 citations

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb11Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network (PARAGON-A); Global Use of Strategies To Open occluded arteries in acute coronary syndromes (GUSTO-IIb).

2001 • 145 citations

Resampling and cross-validation techniques: a tool to reduce bias caused by model building?

1997 • 141 citations

Troponin t levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the gusto-iv trial

2003 • 141 citations

Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression

1999 • 124 citations

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb

2001 • 120 citations

Very Early Risk Stratification Using Combined ECG and Biochemical Assessment in Patients With Unstable Coronary Artery Disease (A Thrombin Inhibition in Myocardial Ischemia [TRIM] Substudy)

1998 • 89 citations

Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina

2003 • 88 citations

Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients

2003 • 82 citations

Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: A TRIM substudy

1999 • 78 citations

Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA

2003 • 57 citations

Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns

2005 • 17 citations

Cited By (0)

Loading...
Short- and Long-Term Risk Stratification in Acute Coronary Syndromes (2006) – Journal of the American College of Cardiology | Metascience Observatory Explorer